Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?

被引:14
|
作者
Moschovi, Maria [1 ]
Adamaki, Maria [1 ]
Vlahopoulos, Spiros [1 ]
Rodriguez-Galindo, Carlos [2 ,3 ]
机构
[1] Univ Athens Aghia Sofia Childrens Hosp, Dept Pediat 1, Pediat Hematol Oncol Unit, Athens 11527, Greece
[2] Dana Farber Boston Childrens Canc, Dept Pediat Hematol & Oncol, Boston, MA USA
[3] Blood Disorders Ctr, Boston, MA USA
关键词
D O I
10.1002/pbc.25173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:173 / 174
页数:2
相关论文
共 50 条
  • [31] BRAF V600E mutation in thyroid nodules in Argentina
    Ilera, Veronica
    Dourisboure, Ricardo
    Colobraro, Antonio
    Silva Croome, Maria Del Carmen
    Olstein, Gustavo
    Gauna, Alicia
    MEDICINA-BUENOS AIRES, 2016, 76 (04) : 223 - 229
  • [32] Adult Onset of BRAF(V600E)-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining
    Tono, Hisayuki
    Fujimura, Taku
    Kakizaki, Aya
    Furudate, Sadanori
    Ishibashi, Masaya
    Aiba, Setsuya
    CASE REPORTS IN DERMATOLOGY, 2015, 7 (03): : 237 - 240
  • [33] Incidental Langerhans cell histiocytosis of the colon with BRAF p.V600E mutation
    Cortazar, Jacqueline M.
    Kim, Annette S.
    BLOOD, 2017, 130 (16) : 1870 - 1870
  • [34] A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
    Thu Dang Anh Phan
    Bao Gia Phung
    Tu Thanh Duong
    Vu Anh Hoang
    Dat Quoc Ngo
    Nguyen Dinh The Trinh
    Tung Thanh Tran
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2021, 55 (02) : 112 - 117
  • [35] BRAF V600E Expression in Langerhans Cell Histiocytosis (LCH): Comparison of Immunohistochemistry with Molecular Studies
    Kip, N. S.
    Parrilla, E. R.
    Rumilla, K. M.
    Roden, A. C.
    Hu, X.
    Vassallo, R.
    Ryu, J. H.
    Yi, E. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 925 - 925
  • [36] Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status
    Mosin S. Khan
    Arshad A. Pandith
    Shariq R. Masoodi
    Khursheed A. Wani
    Mahboob Ul Hussain
    Syed Mudassar
    Endocrine, 2014, 47 : 449 - 455
  • [37] A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
    Robbins, Richard J.
    Thomas, Jessica S.
    Osuna, Patricia Mejia
    Shakil, Jawairia
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [38] Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status
    Khan, Mosin S.
    Pandith, Arshad A.
    Masoodi, Shariq R.
    Wani, Khursheed A.
    Ul Hussain, Mahboob
    Mudassar, Syed
    ENDOCRINE, 2014, 47 (02) : 449 - 455
  • [39] Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
    Xing, Mingzhao
    Alzahrani, Ali S.
    Carson, Kathryn A.
    Shong, Young Kee
    Kim, Tae Yong
    Viola, David
    Elisei, Rossella
    Bendlova, Bela
    Yip, Linwah
    Mian, Caterina
    Vianello, Federica
    Tuttle, R. Michael
    Robenshtok, Eyal
    Fagin, James A.
    Puxeddu, Efisio
    Fugazzola, Laura
    Czarniecka, Agnieszka
    Jarzab, Barbara
    O'Neill, Christine J.
    Sywak, Mark S.
    Lam, Alfred K.
    Riesco-Eizaguirre, Garcilaso
    Santisteban, Pilar
    Nakayama, Hirotaka
    Clifton-Bligh, Roderick
    Tallini, Giovanni
    Holt, Elizabeth H.
    Sykorova, Vlasta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 42 - U79
  • [40] BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence
    Czarniecka, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Barczynski, Marcin
    GLAND SURGERY, 2016, 5 (05) : 495 - 505